Oxygen tension regulates human mesenchymal stem cell paracrine functions

Stem Cells Translational Medicine

Volumn 4, Issue 7, 2015, Pages 809-821

  Paquet, Joseph ^a   Deschepper, Mickael ^a   Moya, Adrien ^a   Logeart Avramoglou, Delphine ^a   Boisson Vidal, Catherine ^b   Petite, Hervé ^a  

^a CNRS   (France)

^b Unité Mixte de Rechrche   (France)

Author keywords

Angiogenesis; Chemotaxis; Cytokines; Human mesenchymal stem cells; Near anoxia and hypoxia; Secretome

Indexed keywords

CD31 ANTIGEN; FIBROBLAST GROWTH FACTOR; HEMOGLOBIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN A; VASCULOTROPIN C;

ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOXIA; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL GROWTH; CELL HYPOXIA; CELL INFILTRATION; CELL VIABILITY ASSAY; CONTROLLED STUDY; CYTOKINE RELEASE; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OXYGEN TENSION; PARACRINE SIGNALING; PROTEIN CONTENT; PROTEIN EXPRESSION; REGULATORY MECHANISM; STEM CELL CULTURE;

EID: 84937019695     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2014-0180     Document Type: Article

References (43)

1. Li R-K, Weisel RD. Cardiac Regeneration and Repair. New York, NY: Elsevier, 2014.
2. Antonic A, Sena ES, Lees JS et al. Stem cell transplantation in traumatic spinal cord injury: a systematic review and metaanalysis of animal studies. PLoS Biol 2013; 11: e1001738.
3. Norambuena GA, Khoury M, Jorgensen C. Mesenchymal stem cells in osteoarticular pediatric diseases: An update. Pediatr Res 2012; 71: 452-458.
4. Jorgensen C, Nöel D. Mesenchymal stem cells in osteoarticular diseases. Regen Med 2011; 6(suppl): 44-51.
5. Ranganath SH, Levy O, Inamdar MS et al. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 2012; 10: 244-258.
6. Eggenhofer E, Luk F, Dahlke MH et al. The life and fate of mesenchymal stem cells. Front Immunol 2014; 5: 148.
7. Hocking AM, Gibran NS. Mesenchymal stem cells: Paracrine signaling and differentiation during cutaneous wound repair. Exp Cell Res 2010; 316: 2213-2219.
8. Kanki S, Segers VF, Wu W et al. Stromal cell-derived factor-1 retention and cardioprotection for ischemic myocardium. Circ Heart Fail 2011; 4: 509-518.
9. Timmers L, Lim SK, Hoefer IE et al. Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res (Amst) 2011; 6: 206-214.
10. Chen L, Mizutani A, Kasai T et al. Mouse induced pluripotent stem cell microenvironment generates epithelial-mesenchymal transition in mouse Lewis lung cancer cells. Am J Cancer Res 2014; 4: 80-88.
11. Ando Y, Matsubara K, Ishikawa J et al. Stem cell-conditioned medium accelerates distraction osteogenesis through multiple regenerative mechanisms. Bone 2014; 61: 82-90.
12. Chimenti I, Smith RR, Li TS et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res 2010; 106: 971-980.
13. Rosová I, Dao M, Capoccia B et al. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. STEM CELLS 2008; 26: 2173-2182.
14. D'Ippolito G, Diabira S, Howard GA et al. Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human MIAMI cells. Bone 2006; 39: 513-522.
15. Grayson WL, Zhao F, Bunnell B et al. Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Biophys Res Commun 2007; 358: 948-953.
16. Fehrer C, Brunauer R, Laschober G et al. Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell 2007; 6: 745-757.
17. Holzwarth C, Vaegler M, Gieseke F et al. Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells. BMC Cell Biol 2010; 11: 11.
18. Potier E, Ferreira E, Andriamanalijaona R et al. Hypoxia affects mesenchymal stromal cell osteogenic differentiation and angiogenic factor expression. Bone 2007; 40: 1078-1087.
19. Annabi B, Lee YT, Turcotte S et al. Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation. STEM CELLS 2003; 21: 337-347.
20. Gnecchi M, Melo LG. Bone marrowderived mesenchymal stem cells: Isolation, expansion, characterization, viral transduction, and production of conditioned medium. Methods Mol Biol 2009; 482: 281-294.
21. Zemani F, Benisvy D, Galy-Fauroux I et al. Low-molecular-weight fucoidan enhances the proangiogenic phenotype of endothelial progenitor cells. Biochem Pharmacol 2005; 70: 1167-1175.
22. Paquet J, Goebel JC, Delauney C et al. Cytokines profiling by multiplex analysis in experimental arthritis: Which pathophysiological relevance for articular versus systemic mediators? Arthritis Res Ther 2012; 14: R60.
23. Bronckaers A, Hilkens P, MartensWet al. Mesenchymal stem/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis. Pharmacol Ther 2014; 143: 181-196.
24. English K. Mechanisms of mesenchymal stromal cell immunomodulation. Immunol Cell Biol 2013; 91: 19-26.
25. Maumus M, Jorgensen C, Nöel D. Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: Role of secretome and exosomes. Biochimie 2013; 95: 2229-2234.
26. Boomsma RA, Geenen DL. Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis. PLoS One 2012; 7: e35685.
27. Maguire G, Friedman P. The systems biology of stem cell released molecules-based therapeutics. ISRN Stem Cells 2013; 2013: 784541.
28. Xu XM, Wang J, Xuan Z et al. Chaperonins facilitate KNOTTED1 cell-to-cell trafficking and stem cell function. Science 2011; 333: 1141-1144.
29. Estrada R, Li N, SarojiniHet al. Secretome from mesenchymal stem cells induces angiogenesis via Cyr61. J Cell Physiol 2009; 219: 563-571.
30. Iwase T, Nagaya N, Fujii T et al. Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia. Cardiovasc Res 2005; 66: 543-551.
31. Presta M, Andrés G, Leali D et al. Inflammatory cells and chemokines sustain FGF2-induced angiogenesis. Eur Cytokine Netw 2009; 20: 39-50.
32. Bernardo ME, Fibbe WE. Mesenchymal stromal cells: Sensors and switchers of inflammation. Cell Stem Cell 2013; 13: 392-402.
33. Roddy GW, Oh JY, Lee RH et al. Action at a distance: Systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-a stimulated gene/protein 6. STEM CELLS 2011; 29: 1572-1579.
34. Waterman RS, Tomchuck SL, Henkle SL et al. A new mesenchymal stem cell (MSC) paradigm: Polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype. PLoS One 2010; 5: e10088.
35. Waterman RS, Henkle SL, Betancourt AM. Mesenchymal stem cell 1 (MSC1)-based therapy attenuates tumor growth whereas MSC2-treatment promotes tumor growth and metastasis. PLoS One 2012; 7: e45590.
36. Estrada JC, Albo C, Benguría A et al. Culture of human mesenchymal stem cells at low oxygen tension improves growth and genetic stability by activating glycolysis. Cell Death Differ 2012; 19: 743-755.
37. Chen L, Xu Y, Zhao J et al. Conditioned medium from hypoxic bone marrow-derived mesenchymal stem cells enhances wound healing in mice. PLoS One 2014; 9: e96161.
38. Jun EK, Zhang Q, Yoon BS et al. Hypoxic conditioned medium from human amniotic fluid-derived mesenchymal stem cells accelerates skin wound healing through TGF-b/SMAD2 and PI3K/Akt pathways. Int J Mol Sci 2014; 15: 605-628.
39. Cheema U, Brown RA, Alp B et al. Spatially defined oxygen gradients and vascular endothelial growth factor expression in an engineered 3D cell model. Cell Mol Life Sci 2008; 65: 177-186.
40. Lu C, RollinsM, HouHet al. Tibial fracture decreases oxygen levels at the site of injury. Iowa Orthop J 2008; 28: 14-21.
41. Brighton CT, Krebs AG. Oxygen tension of nonunion of fractured femurs in the rabbit. Surg Gynecol Obstet 1972; 135: 379-385.
42. Bland E, Dréau D, Burg KJL. Overcoming hypoxia to improve tissue-engineering approaches to regenerative medicine. J Tissue Eng Regen Med 2013; 7: 505-514.
43. Becquart P, Cambon-Binder A, Monfoulet LE et al. Ischemia is the prime but not the only cause of human multipotent stromal cell death in tissue-engineered constructs in vivo. Tissue Eng Part A 2012; 18: 2084-2094.